| URL | https://www.fiercepharma.com/manufacturing/accord- |
| Source | Fierce Pharma |
| Date Published | 11/16/2023 |
| Author Name | Joseph Keenan |
| Company/Division name | Accord Healthcare |
| Parent company | Intas Pharmaceuticals |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2023 |
| Year reshoring implemented or to be implemented: | 2023 |
| Country(ies) from which reshored: | India |
| City reshored to: | Durham |
| State(s) reshored to: | NC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | cancer drug cisplatin |